Skip to search formSkip to main contentSkip to account menu

DOXO-EMCH

Known as: Aldoxo, Aldoxorubicin, Doxorubicin-EMCH 
A 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. Following… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Soft Tissue Sarcoma (STS) encompasses a number of different clinical entities and is a rare form of cancer. This review focuses… 
2017
2017
In this interview we discuss the phase III trial of aldoxorubicin in patients with advanced soft-tissue sarcoma, which showed… 
2016
2016
Aldoxorubicin yielded significantly better progression-free survival over investigator’s choice of various chemotherapy options… 
Review
2014
Review
2014
10502 Background: Doxorubicin (D) is the only approved first line therapy for most advanced soft tissue sarcomas (STS… 
2012
2012
Alzheimer Disease (AD) is the most common form of dementia, and its prevalence is predicted to increase even further because of… 
2008
2008
B111 Introduction Doxorubicin is an anthracycline antibiotic with potent anticancer activity used widely against human neoplasms… 
2005
2005
AIM:To study the reversal of resistance to doxoru bi cin by CJX1,an amlodipine derivative, in doxorubicin-resistant human… 
2005
2005
Assistant Psychologist, Letchworth Village. List Established August 20, 1937 Dorothy E. Jones, 529 Church Street, Newark, N. Y… 
2002
2002
The demand for health models explain how health care choices result from managerial decisions concerning human capital. But these… 
1995
1995
Helmut HOLZHEY: Einfuhrung. INDIVIDUELLE ZEUGNISSE. Angelica BAUM, Brigitte SCHNEGG: Cette faiblesse originelle de nos nerfs…